← Eichor
Condition: Cns Tumor Childhood Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cns Tumor Childhood

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
EARLY_Phase 1 · 12 location(s) · C17 Council · NCT06942039Whole Body Metabolism in Children Before and After Treatment of CNS Tumor
NA · 1 location(s) · Rigshospitalet, Denmark · NCT06380387International HIT-MED Registry (I-HIT-MED)
Phase N/A · 57 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT02417324Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Phase 1 · 1 location(s) · Children's National Research Institute · NCT06193759Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
Phase 1/Phase 2 · 12 location(s) · Centre Leon Berard · NCT07243470The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors
Phase 2 · 1 location(s) · Beijing Tiantan Hospital · NCT05124951Somatic Mosaicism in Twins Discordant for Childhood Cancer
Phase N/A · 1 location(s) · Children's Oncology Group · NCT06054295Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Phase 1/Phase 2 · 14 location(s) · Australian & New Zealand Children's Haematology/Oncology Gro · NCT06208657rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
Phase 1 · 3 location(s) · Ann & Robert H Lurie Children's Hospital of Chicago · NCT04943848Magnetoencephalography in Children
Phase N/A · 1 location(s) · Children's Hospital of Fudan University · NCT06668519Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric P
Phase 1 · 5 location(s) · ITM Solucin GmbH · NCT06441331Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue
Phase 3 · 4 location(s) · Odense University Hospital · NCT06905587Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Phase 2 · 10 location(s) · St. Jude Children's Research Hospital · NCT05535166European Prospective Investigation Into Childhood Cancer
Phase N/A · 1 location(s) · Columbia University · NCT05375617Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Gliom
Phase 1 · 1 location(s) · Seattle Children's Hospital · NCT04185038GD2-CAR T Cells for Pediatric Brain Tumours
Phase 1 · 1 location(s) · Bambino Gesù Hospital and Research Institute · NCT05298995Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
Phase N/A · 1 location(s) · Children's National Research Institute · NCT01106794Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years
NA · 3 location(s) · University Hospital, Angers · NCT06618703Project: Every Child for Younger Patients With Cancer
Phase N/A · 278 location(s) · Children's Oncology Group · NCT02402244HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 · 3 location(s) · M.D. Anderson Cancer Center · NCT03911388Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Phase 1 · 1 location(s) · Theodore S. Johnson · NCT05106296Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06420076Biomarkers of Brain Injury in Children With Brain Tumors
Phase N/A · 1 location(s) · Uppsala University · NCT07381959
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.